Replies to post #440325 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

and they still haven't updated the trial registry. Why is that?

You could also - instead of asking one of the possibly most debated issues on this board - get acquainted with the basics?

You can start here. No need to thank me.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159462764

[biosectinvestor]

They weren’t “hiding” it, for some reason it seemed that being discrete in their regulatory dealings was the wise move. You can claim they “hid” something but regulatory communications are not necessarily best doled out as press releases even if that can temporarily goose a stock. It creates implications that can backfire and that are not ideal conditions for dealing with regulators on a confidential basis.

So for whatever reason, a reason you and we do not know, they apparently felt it was more conducive to harmonious relations with their regulators to stay quiet. That is their choice. No one has to agree with it. One might not understand it or like it, but it is a reasonable choice,

[flipper44]

I am saying it was stupid of AVXL and NWBO to wait to make the changes on the u.s. clinical trial registry.

NWBO should have made the change a year and a half ago when they changed endpoints.

I bet it was Les that has stood up against making the change earlier. NWBO needs to put their egos aside and update the registry.

(NWBO’s changes to endpoints were not last second, but they still have not changed the U.S. clinical trial registry, which bears will undoubtedly twist.)